Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhaolian Cai
Cyr61 Regulates the Chemosensitivity of Chronic Myeloid Leukemia to Imatinib Mesylate Through the NF ‐κB/Bcl‐2 Pathway
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
Cyr61 Decreases Cytarabine Chemosensitivity in Acute Lymphoblastic Leukemia Cells via NF-κB Pathway Activation
International Journal of Molecular Medicine
Medicine
Genetics
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Cyr61 Participates in the Pathogenesis of Acute Lymphoblastic Leukemia by Enhancing Cellular Survival via the AKT/NF-κB Signaling Pathway
Scientific Reports
Multidisciplinary
COX-2 Regulates E-Cadherin Expression Through the NF-κB/Snail Signaling Pathway in Gastric Cancer
International Journal of Molecular Medicine
Medicine
Genetics
PTEN Regulates BCRP/ABCG2 and the Side Population Through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
PLoS ONE
Multidisciplinary
Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate
Oncologist
Cancer Research
Medicine
Oncology